Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 1, single-center , open-label, randomized, 6-sequence, 3-period, 3-treatment crossover study to assess pharmacokinetic drug-drug interaction between baloxavir marboxil and oseltamivir in healthy adult male subjects

Trial Profile

A phase 1, single-center , open-label, randomized, 6-sequence, 3-period, 3-treatment crossover study to assess pharmacokinetic drug-drug interaction between baloxavir marboxil and oseltamivir in healthy adult male subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Oct 2018

At a glance

  • Drugs Baloxavir-marboxil (Primary) ; Oseltamivir (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 04 Oct 2018 Results published in the Clinical Drug Investigation
    • 10 Sep 2018 Results evaluating drug-drug interaction potential between Baloxavir Marboxil and Oseltamivir published in the Clinical Drug Investigation.
    • 08 May 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top